FDA Approves Ibrance to Treat Advanced Breast Cancer
For postmenopausal women with ER+, HER2− metastatic breast cancer
Guidelines for VTE Prophylaxis, Treatment in Cancer Unchanged
Thromboprophylaxis required throughout hospitalization for most patients with active cancer
January 2015 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for January 2015. This roundup includes...
CIO: Bacteria Could Be Useful in Fight Against Cancer
Weakened strain of Clostridium novyi-NT bacteria thrives in low oxygen environment
Recommendations Presented for MRI Use in Multiple Myeloma
MRI is gold standard for imaging axial skeleton, assessing painful lesions, ID'ing benign fractures
Patient Engagement Can Cut Costs, Improve Outcomes
Initiatives can decrease hospital visits, cut morbidity and mortality, up treatment adherence
Cancer Diagnosis Impacts Patient Adherence to Diabetes Rx
Effect more pronounced with poor cancer prognosis
Topical Acne Gel Linked to Methemoglobinemia
Teen developed blood disorder after using Aczone for a week
Deep Inspiration Breath-Hold Cuts Mean Heart Radiation Dose
Review shows reduction in mean heart dose versus free breathing approach in left breast irradiation
Colorectal Cancer Rates on Rise in Young Americans
Still, only 10 percent of cases occur in younger group, researchers find
